The Parkinson's-Reversing Breakthrough

Cure for Parkinsons

Get Instant Access

1. Adachi M, Hosoya T, Haku T, et al. (1999) Evaluation of the substantia nigra in patients with Parkinsonian syndrome accomplished using multishot diffusion-weighted MR imaging. Am J Neuroradiol 20:1500-1506

2. Alexander GE, DeLong MR, Strick PL (1986) Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu RevNeurosci 9:357-381

3. Antonini A, Leenders KL, Meier D, et al. (1993) T2 relaxation time in patients with Parkinson's disease. Neurology 43:697-700

4. Bartzokis G, Cummings JL, Markham CH, et al. (1999) MRI evaluation of brain iron in earlier- and later-onset Parkinson's disease and normal subjects. Magn Reson Imaging 17:213-222

5. Brooks DJ (2004) Neuroimaging in Parkinson's disease. NeuroRx 1:243-254

6. Burton EJ, McKeith IG, Burn DJ, et al. (2004) Cerebral atrophy in Parkinson's disease with and without dementia: a comparison with Alzheimer's disease, dementia with Lewy bodies and controls. Brain 127:791-800

7. Eckert T, Sailer M, Kaufmann J, et al. (2004) Differentiation of idiopathic Parkinson's disease, multiple system atrophy, progressive supranuclear palsy, and healthy controls using magnetization transfer imaging. Neuroimage 21:229-235

8. Graham JM,Paley MN, GrunewaldRA, et al. (2000) Brain iron deposition in Parkinson's disease imaged using the PRIME magnetic resonance sequence. Brain 123(12): 2423-2431

9. Haslinger B, Erhard P, Kampfe N, et al. (2001) Event-related functional magnetic resonance imaging in Parkinson's disease before and after levodopa. Brain 124:558-570

10. Hu MT, White SJ, Herlihy AH, et al. (2001) A comparison of (18)F-dopa PET and inversion recovery MRI in the diagnosis of Parkinson's disease. Neurology 56:1195-1200

11. Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy ofclinical diagnosis ofidiopathic Parkinson's disease: a cli-nico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55:181-184

12. Hutchinson M, Raff U (2000) Structural changes of the substantia nigra in Parkinson's disease as revealed by MR imaging. Am J Neuroradiol 21:697-701

13. Hutchinson M, RaffU, LebedevS(2003) MRI correlates of pathology in parkinsonism: segmented inversion recovery ratio imaging (SIRRIM). Neuroimage 20:1899-1902

14. Jahanshahi M, Jenkins IH, Brown RG, et al. (1995) Self-initiated versus externally triggered movements. I. An investigation using measurement of regional cerebral blood flowwith PET and movement-related potentials in normal and Parkinson's disease subjects. Brain 118(4):913 -933

15. Kosta P, Argyropoulou MI, Markoula S, Konitsiotis S (2005) MRI evaluation of the basal ganglia size and iron content in patients with Parkinson's disease. J Neurol (in press)

16. Lehericy S, Ducros M, Van de Moortele PF, et al. (2004) Diffusion tensor fiber tracking shows distinct corticostria-tal circuits in humans. Ann Neurol 55:522-529

17. Oikawa H, Sasaki M, Tamakawa Y, et al. (2002) The substantia nigra in Parkinson disease: proton density-weighted spin-echo and fast short inversion time inversion-recovery MR findings. Am J Neuroradiol 23: 1747 -1756

18. Playford ED, Jenkins IH, Passingham RE, et al. (1992) DJ impaired mesial frontal andputamen activation in Parkinson's disease: a positron emission tomography study. Ann Neurol 32:151-161

19. Rademacher J, Engelbrecht V, Burgel U, et al. (1999) Measuring in vivo myelination of human white matter fiber tracts with magnetization transfer MR. Neuroimage 9: 393-406

20. Rascol O, Sabatini U, Chollet F, et al. (1992) Supplementary and primary sensory motor area activity in Parkinson's disease. Regional cerebral blood flow changes during finger movements and effects of apomorphine. Arch Neurol 49:144-148

21. Rascol O, Sabatini U, Chollet F, et al. (1994) Normal activation of the supplementary motor area in patients with Parkinson's disease undergoing long-term treatment with levodopa. J Neurol Neurosurg Psychiatry 57:567-571

22. Ryvlin P, Broussolle E, Piollet H, et al. (1995) Magnetic resonance imaging evidence of decreased putamenal iron content in idiopathic Parkinson's disease. Arch Neurol 52: 583-588

23. Sabatini U, Boulanouar K, Fabre N, et al. (2000) Cortical motor reorganization in akinetic patients with Parkinson's disease: a functional MRI study. Brain 123(2):394-403

24. Samuel M, Ceballos-Baumann AO, Boecker H, Brooks DJ (2001) Motor imagery in normal subjects and Parkinson's disease patients: an H215O PET study. Neuroreport 12:821 -828

25. Schocke MF, Seppi K, Esterhammer R, et al. (2002) Diffusion-weighted MRI differentiates the Parkinson variant of multiple system atrophy from PD. Neurology 58:575 - 580

26. Schocke MF, Seppi K, Esterhammer R, et al. (2004) Trace of diffusion tensor differentiates the Parkinson variant of multiple system atrophy and Parkinson's disease. Neuroimage 21:1443-1451

27. Seppi K, Schocke MF, Donnemiller E, et al. (2004) Comparison of diffusion-weighted imaging and [ 123I]IBZM-SPECT for the differentiation of patients with the Parkinson variant of multiple system atrophy from those with Parkinson's disease. Mov Disord 19:1438-1445

28. Seppi K, Schocke MF, Esterhammer R, et al. (2003) Diffusion-weighted imaging discriminates progressive supranuclear palsy from PD, but not from the Parkinson variant of multiple system atrophy. Neurology 60:922-927

29. Summerfield C, Junque C, Tolosa E, et al. (2005) Structural brain changes in Parkinson disease with dementia: a voxel-based morphometry study. Arch Neurol 62:281 -285

30. Ye FQ, Allen PS, Martin WR (1996) Basal ganglia iron content in Parkinson's disease measured with magnetic resonance. Mov Disord 11:243-249

31. Youdim MB, Riederer P (2004) A review about brain iron in normal and pathological conditions. In: Encyclopedia of neuroscience. Elsevier, Amsterdam

32. Zecca L, Youdim MB, Riederer P, et al. (2004) Iron, brain ageing and neurodegenerative disorders. Nat RevNeurosci 5:863-873

Was this article helpful?

0 0
All About Alzheimers

All About Alzheimers

The comprehensive new ebook All About Alzheimers puts everything into perspective. Youll gain insight and awareness into the disease. Learn how to maintain the patients emotional health. Discover tactics you can use to deal with constant life changes. Find out how counselors can help, and when they should intervene. Learn safety precautions that can protect you, your family and your loved one. All About Alzheimers will truly empower you.

Get My Free Ebook

Post a comment